Rocket Lab (RKLB) Zen Horizon Research Report

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

• QHow high is its market ceiling? Is it expanding an existing pie, or creating an entirely new market?5/10

  A

  It is doing both, but for now it is mainly expanding an existing pie rather than creating a brand-new market. Baillie Gifford LTGG cares most about whether a company can create new demand from scratch. Rocket Lab scores above average on that test, but not at the extreme high end. Its ceiling is real and substantial, yet the story is about taking the second scaled seat in the launch economy that SpaceX has already opened up, not about opening untouched territory.

  Start with the size of the pie. The global space economy is currently around $600 billion, and multiple institutions forecast expansion toward $1.8 trillion in the 2040s (Morgan Stanley) or $1.8 trillion by 2035 (World Economic Forum / McKinsey), across launch, satellites, and on-orbit services. This pie is indeed getting larger, driven by defense (SDA, Golden Dome), low-Earth-orbit constellations (Starlink, Kuiper), and multiple rounds of Earth observation demand, so the runway for expanding an existing pie is itself long enough.

  But Rocket Lab's current cash cow, Electron, sits in a structurally small niche: small rockets for less than 1 tonne to LEO. The report discloses Electron's market share at 80%+, but this type of launch occurs fewer than 100 times globally each year, with a unit price of only $15 million. In other words, it is a big fish in a small pond, and the pond itself caps the ceiling. The real ceiling can only be lifted by two not yet delivered items: (1) the Neutron medium-lift rocket (13 tonnes to LEO, with pricing stepping up to $50 million), which would move it into the main battlefield where SpaceX Falcon 9 holds roughly 80% share and let it take share from the installed market; (2) the Geost acquisition ($275 million) plus large SDA defense orders, which would upgrade it from a launch provider to a full-stack prime defense contractor competing for defense budgets held by Lockheed and Northrop.

  Both items are fundamentally about taking share in an existing large pie, not creating a market that did not exist before. Launch services, defense satellites, and missile-warning sensors are all mature demand pools. Rocket Lab is using vertical integration and lower cost to reallocate supply. The only element with some flavor of market creation is its bundling of rocket, satellite, payload, and on-orbit services into a one-stop full-stack offering, lowering the barrier for smaller customers to enter space. That has a marginal market-expansion effect, but the scale is limited.

  The honest Baillie Gifford view: the ceiling is high enough to support a company with tens of billions of dollars in revenue, and the long runway is real. But this is a story of scaling by taking pie, not creating pie out of nothing. It lacks the exponential expansion quality Baillie Gifford most loves, where a company itself pushes the demand curve outward. That is also why its growth imagination depends so heavily on Neutron as a binary event. Only when it moves from a small pond into the ocean does the pie truly become larger.

  Jun 10, 2026
• QCan its revenue at least double over the next five years? Will growth mainly be driven by volume, price, or new businesses?6/10

  A

  It can almost certainly double, and it will probably more than double. This is Rocket Lab's strongest bull argument. Growth is driven mainly by the twin engines of volume and new businesses, with price as a secondary contributor. When Baillie Gifford asks whether revenue can at least double in five years, Rocket Lab faces a low bar: the starting base is low, backlog is thick, and the new engine, Neutron, is about to scale.

  Start with the base and slope. FY2025 revenue was $602 million, up +38% year over year; Q1 2026 revenue was $200.3 million, up +63.5% year over year, breaking $200 million for the first time; and Q2 2026 guidance is $225-240 million. A simple linear extrapolation of the current growth rate points FY2026 toward $900 million-$1.0 billion. That means revenue from the existing Electron + Space Systems business alone, without Neutron, is already close to doubling within two years. The five-year doubling threshold, to roughly $1.2 billion, is far behind.

  There are three growth forces, ranked by contribution:

  (1) New businesses are the largest increment: Space Systems plus full-stack defense. This is already the main revenue contributor (Q1 2026 Space Systems revenue was $136.7 million, about 68% of total revenue). SDA is the core engine: the August 2024 Transport Layer-Beta contract, worth $515 million for 18 satellites, was its defense prime debut; in December 2025 it won another $816 million Tracking Layer missile-defense constellation prime contract; and cumulative SDA awards now exceed $1.3 billion. Note: the report text misstates the $816 million award as the Tracking contract signed in 2024-08. In fact, 2024-08 was the $515 million Transport contract, and the $816 million award was a separate Tracking contract in 2025-12. The two add together. The Geost acquisition adds EO/IR sensor-payload revenue on top.

  (2) Volume is the second force: both launch cadence and satellite deliveries are rising. FY2025 saw 21 Electron launches with a 100% success rate, and FY2026 guidance is 25+ launches. The Department of War placed a $190 million, 20-test hypersonic flight block order for HASTE, further locking in launch volume.

  (3) Price is the amplifier, but it has to wait for Neutron. Electron's $15 million unit price is almost capped out because of small-rocket competition and ride-share substitution. The real price step-up comes from Neutron at $50 million per launch. If the Q4 2026 maiden flight succeeds and volume ramps, FY2027 onward should see a step-function increase in per-launch revenue of about 3x.

  The honest Baillie Gifford view: this is Rocket Lab's highest-scoring dimension across all ten questions. Backlog has reached $2.2 billion, more than doubling year over year, equivalent to almost 4x current annualized revenue, a highly visible future revenue reservoir. The question is not whether revenue can double in five years, but how many times it can double. The one caveat: revenue doubling does not mean profit doubling. The company is still loss-making (see Q8). Growth is real; profits are still on the way.

  Jun 10, 2026
• QAfter five years, what will take over as the next growth engine? Does that second curve exist today?5/10

  A

  The second curve already exists today, and it is visible and tangible: Neutron plus full-stack defense. That is stronger than most early-stage growth companies. When Baillie Gifford asks who takes over after five years, the fear is that the current engine is reaching its ceiling while the next one still exists only in a slide deck. Rocket Lab is in the opposite position: the current cash cow, the Electron small rocket, has limited scale and is already close to its growth ceiling, but the successor is already being built in the factory and orders have already been signed. The only question is whether it can ignite on time.

  The first curve, Electron small rockets, is topping out. The unit price is $15 million, the global small-rocket market has fewer than 100 launches per year, and market share is already 80%+. There is limited room left upward. Electron is more like a stable cash cow plus engineering training ground than the main growth driver.

  Second curve one: the Neutron medium-lift rocket, the most important successor. It has 13 tonnes of LEO capacity, about $50 million per launch, reusability, and a maiden flight targeted for 2026 Q4. It moves Rocket Lab from small-rocket specialist into the medium and large launch battlefield where SpaceX Falcon 9 holds about 80% share. By Q1 2026, Rocket Lab had signed 5 Neutron contracts and secured the largest deal in company history with an undisclosed customer through 2029. The second curve is not imagination. It is real demand with paying customers already in line. That is the hard foundation separating it from pure cash-burning moonshots such as the lunar lander company LUNR.

  Second curve two: full-stack defense contractor. The Geost acquisition ($275 million, EO/IR infrared/electro-optical sensor payloads) upgrades it from launch + spacecraft into a company that can build missile-warning payloads itself and bid against Lockheed/Northrop/Raytheon for large Pentagon contracts. Add more than $1.3 billion in cumulative SDA awards and the hundred-billion-dollar Golden Dome missile-defense blueprint, and this curve's ceiling is an order of magnitude higher than Electron's.

  Third curve, further out: on-orbit services plus Photon platform extension. The Photon satellite platform already has deep-space and on-orbit management capabilities. Over the long term it could enter Northrop MEV-style markets such as on-orbit life extension and space-domain awareness, but this bucket is still early and contributes little today.

  The honest Baillie Gifford view: on the existence of a second curve, Rocket Lab scores clearly above most unprofitable growth companies. The successor is not a castle in the air. It is a built, ordered, and verification-pending physical product. But there is a fatal sequencing concentration risk: the success or failure of the second curve is almost entirely tied to Neutron's first launch (already delayed three times from late 2025 to 2026 Q4, triggered by a first-stage fuel-tank test failure). Baillie Gifford likes multiple curves with diversified bets. Rocket Lab is more of a thick single curve plus a binary ignition point. The curve itself is solid, but the probability at the moment of ignition decides whether succession works or the narrative collapses (see Q9 and Q10).

  Jun 10, 2026
• QWhat is its core competitive advantage? Will this moat widen or narrow over the next three to five years?4/10

  A

  The core advantage is the combination of full-stack vertical integration, Electron's de facto monopoly in small rockets, and long government contracts. Over the next three to five years, the moat should first widen and then face a test. Its purity is moderate, and it is far from SpaceX-level depth. Baillie Gifford wants a moat that widens over time. Rocket Lab has real levers for widening, but every moat comes with a caveat.

  First moat: Electron's de facto monopoly in small rockets, the most concrete but also the smallest pond. It has 80%+ share in the sub-1-tonne LEO segment, 21 launches in FY2025, and a 100% success rate. Competitor Firefly Alpha cannot match its cadence, and Astra has already gone through bankruptcy restructuring. A new entrant has to redesign a rocket, pass FAA certification, and build customer trust; that starts at 5+ years. But the segment is too small (global annual launches < 100), so the absolute value of the monopoly is limited, and Falcon 9 ride-share creates substitution from above.

  Second moat: full-stack vertical integration, the most differentiated advantage and the main engine of moat widening. Rocket Lab builds rockets, satellite platforms (Photon), payloads (Geost), and on-orbit services itself, capturing 3-4 layers of gross margin within the same project and reducing dependence on external suppliers. This is its structural advantage over single-rocket manufacturers such as Firefly and Relativity, and the underlying reason gross margin could rise from 26% in FY2024 to a Q1 2026 record of 38.2% GAAP / 43% non-GAAP. This moat should widen over the next three to five years, as Geost integration internalizes payload supply and Neutron further internalizes launch cost.

  Third moat: long government defense contracts as ballast. The $515 million SDA Transport plus $816 million Tracking prime contracts, with cumulative awards above $1.3 billion, and the $190 million / 20-test HASTE block order are stable, high-margin cash flows over 5-7 years. Once a company becomes a prime contractor, supplier switching costs are extremely high. But government orders are a double-edged moat. They are both a barrier and a dependency: the report notes government orders account for 50%+ of backlog, leaving the business exposed to budget and political cycles (see Q7).

  The key variable for moat widening is Neutron. If the 2026 Q4 maiden flight succeeds, Rocket Lab expands from small rockets + satellites into the medium reusable rocket market, materially deepening the moat. If it fails, the company is pushed back to its original shape and its execution shortcomings are exposed.

  The honest Baillie Gifford view: the report's self-assessed moat score is 5/10 (SpaceX 10, traditional large-rocket giants 7), and I agree with that order of magnitude. The moat is real and directionally widening, but it is narrow rather than deep: the monopoly is in a small pond, full-stack integration is an advantage but not yet fully proven through profits, and government contracts are both a barrier and an Achilles' heel. Compared with SpaceX's one-pole dominance across rockets, constellation, and full reusability, Rocket Lab is a high-quality number two. The width of its moat is heavily tied to an engineering event that has not yet happened. This is not a Buffett-style moat that collects rent while lying still; it is a moat still being dug, with a major wager halfway through the digging.

  Jun 10, 2026
• QIf its core business is disrupted, does it have the genes for self-reinvention? How does it handle mistakes and bad news?5/10

  A

  Its self-reinvention genes are strong, and its handling of mistakes is candid and transparent. This is a genuine cultural plus for Rocket Lab. Baillie Gifford puts special weight on whether a company can be reborn if its core business is disrupted and how management faces bad news, because that determines whether a company can survive ten years and multiple paradigm shifts. Rocket Lab has fairly solid evidence on this dimension.

  Reinvention gene one: multiple self-directed leaps from sounding rockets to orbital launch to full-stack defense. The report's longitudinal history is itself a reinvention story. In 2009 it was still building the Ātea-1 sounding rocket in New Zealand; in 2018 Electron became the world's first battery-pump rocket from a private launch site to reach orbit; from 2024 onward it transformed into an SDA defense prime. A company that can move over two decades from suborbital to small rockets to medium rockets to satellite manufacturing to payloads to on-orbit services has regenerative capacity in its organizational DNA: it does not cling to one product, and it actively attacks both upstream and downstream along the value chain.

  Reinvention gene two: engineering resilience after failure. Electron's 2017 maiden flight failed because of a third-stage issue, and the 2022 "Wall of Light" mission suffered a second-stage failure. After each failure, Rocket Lab identified the root cause, fixed it, and later achieved 21 consecutive successes and a 100% annual success rate. In rockets, the cycle of fail, diagnose, and fly successfully again is an extreme stress test for handling bad news. Rocket Lab passed it.

  Attitude toward mistakes: candid, unsparing, and specific about root causes. The most persuasive current case is Neutron. The company did not hide behind vague language. It explicitly attributed the maiden-flight delay to a "first-stage fuel tank test failure" and publicly laid out the three-delay timeline (late 2025 → 2026 Q2 → 2026 Q4), while explaining mitigation measures (automation plus design changes, with R&D peaking in Q1 2026). This discipline of admitting delay rather than flying sick is exactly what Baillie Gifford appreciates: disclose bad news early, explain the root cause clearly, and do not force a launch just to protect the share price.

  The honest Baillie Gifford view: this is a relatively high-scoring soft dimension for Rocket Lab. It has real reinvention genes (a chain of transformations plus return-to-flight after failures) and a healthy bad-news culture (transparent disclosure, engineering before face). The one discount: so far, its reinventions have been offensive expansions it chose to pursue. It has not yet gone through an existential crisis where the core business is disrupted by external forces and the company is forced into a corner. For example, if SpaceX Starship drives launch costs to a level where Electron/Neutron cannot compete, Rocket Lab's ability to reinvent itself again remains unproven. It has the genes for reinvention, but those genes have not yet been battle-tested in a disruption scenario rather than an expansion scenario.

  Jun 10, 2026
• QDoes management, especially the founder, have a long-term perspective, with interests deeply aligned with the company? Is it willing to sacrifice current profits for the next five to ten years?6/10

  A

  The alignment is strong, the time horizon is long, and the company is clearly willing to sacrifice current profits for the next five to ten years. This is one of Rocket Lab's steadiest scores in the Baillie Gifford framework. Baillie Gifford LTGG treats founder presence, deep alignment of interests, and willingness to sacrifice near-term profit for the long term almost as first-order filters, because only that kind of management can endure patient investment over a ten-year horizon. Rocket Lab hits all three.

  The founder is still in place and remains both the technical and spiritual core. Peter Beck founded the company in New Zealand in 2006, came from a self-taught aerospace engineering background, received a knighthood (Sir Peter Beck), and remains CEO today. The report explicitly describes him as both founder and controlling shareholder, with a long-term industrial-capital perspective. That is exactly the configuration Baillie Gifford likes most: the person at the helm is both designer and major shareholder, and decision incentives are highly aligned with long-term shareholders rather than a professional manager's tenure game.

  Interests are deeply aligned. As a controlling shareholder, Beck's personal wealth moves with the company's market value. This is far stronger than the type of company where the founder has long since become an adviser and the CEO owns only a fraction of a percent. When the leader's net worth is tied to the stock, he is naturally less likely to sacrifice a ten-year technical roadmap for one or two quarters of reported results.

  The hardest evidence: the company has already sacrificed current profits for the long term, and continues to do so. This is not a slogan. It is real cash burn:

  • FY2025 still had a net loss of $198.2 million and Adjusted EBITDA of -$101.2 million. The company could have slowed Neutron and Geost spending and moved faster toward breakeven, but it chose to keep reinvesting profit into R&D.
  • After Neutron's first-stage fuel-tank test failure, Rocket Lab preferred to delay the maiden flight three times and add R&D and CapEx rather than fly sick. It traded short-term disappointment for long-term reliability.
  • The $275 million Geost acquisition in 2025-05 to upgrade full-stack defense capability is a classic case of sacrificing current cash to buy a moat ten years out.

  The "CEO personal risk" in the report's risk list confirms the depth of alignment from the other side. The market worries that if Beck leaves, the company narrative would be hit precisely because he is both the technical core and the marketing core. Key-person dependence is a risk, but it is also the other side of deep founder-company alignment.

  The honest Baillie Gifford view: on this dimension, Rocket Lab meets almost all of Baillie Gifford's preferences: founder in seat, controlling shareholder, and long-termism proven through real losses. Two points require balance: (1) excessive reliance on a single founder, creating succession / departure risk; (2) the flip side of sacrificing profits for the future is persistent lack of profitability and ongoing cash burn. Fortunately, the company had $1.21 billion in cash at the end of Q1 2026 and more than $2.0 billion of available liquidity, so it has enough ammunition and no near-term survival threat. Management's time horizon and alignment are among the least questionable parts of this company.

  Jun 10, 2026
• QIf it disappeared tomorrow, how much would customers miss it? Is its growth model sustainable and not dependent on harming society or regulatory arbitrage?5/10

  A

  Customers would miss it quite a lot, and in defense it is already close to indispensable. Its growth model is sustainable and does not rely on social harm or regulatory arbitrage. Rocket Lab is solid and positive on this dimension. Baillie Gifford's question has two layers: indispensability, meaning how much pain customers would feel if it disappeared, and social/regulatory sustainability of growth, meaning whether the way it makes money is healthy and durable. It needs to pass both.

  Layer one, indispensability: in two niches, it is already hard to replace.

  • Dedicated small-rocket launches: Electron has 80%+ share in the sub-1-tonne LEO segment and a 100% annual success rate. For small-satellite customers that need dedicated orbit, precise insertion, and their own schedule, Falcon 9 ride-share cannot replace it; ride-share must accommodate the primary payload's orbit and launch window. These customers would genuinely miss it.
  • The U.S. defense need for supplier diversification: this is the deeper form of indispensability. The Pentagon clearly does not want SpaceX to dominate alone. It needs an alternative that has scale, can act as prime, and is not SpaceX. Rocket Lab fits that slot exactly. SDA cumulative awards exceed $1.3 billion, and HASTE won a $190 million hypersonic flight-test block order. Part of Rocket Lab's indispensability comes from the scarce identity of being "not SpaceX", and that identity is highly valuable in a defense system that is alert to single-supplier risk.

  A fair discount: in the main battlefield of medium and large commercial launch, it is not yet indispensable. That is Falcon 9's world, and Neutron has not flown. So customer miss-rate is high in small rockets and defense, but weak in large commercial launch.

  Layer two, social and regulatory sustainability of growth: healthy, even with tailwinds.

  • It does not make money by harming society: revenue comes from launch services, satellite manufacturing, and defense payloads. These are tangible hard-tech deliveries, not data arbitrage, regulatory gray zones, or a model that externalizes costs onto society.
  • Regulation is not a headwind; it is more of a tailwind: Rocket Lab has applied to the FAA for a full-year 2026 launch-window permit for Neutron's maiden flight, and the company has long operated compliantly across launch sites in New Zealand and the United States. More importantly, U.S. policy priorities around space sovereignty, supplier diversification, and Golden Dome missile defense push orders toward Rocket Lab rather than restricting it.
  • Two sustainability variables need to be flagged: (1) ITAR export controls restrict non-U.S. customers, and the report already lists this as a risk. It is a structural constraint from the defense profile. (2) High government revenue dependence, with 50%+ of backlog from government, means its social license is tied to U.S. fiscal and political cycles. That is not social harm, but sustainability is indeed affected by external political variables.

  The honest Baillie Gifford view: Rocket Lab stands up on this dimension. In small rockets and as the non-SpaceX defense alternative, it is already close to indispensable; its growth model is clean and aligned with national-strategy tailwinds, with no "profit by harming others" dynamic. The weak point is not whether it harms society, but customer overconcentration in government. Its sustainability does not depend on harming society, but it does depend heavily on continued spending by one buyer, the U.S. government (closely related to Q7's regulatory/political sustainability).

  Jun 10, 2026
• QWhat are the unit economics of this business (gross margin, incremental returns)? Do they improve or deteriorate with scale? Where does the money it earns go?4/10

  A

  Unit economics are improving quickly, but the absolute level is still loss-making: gross margin is rising and the scaling direction is right, yet the company has not reached positive free cash flow. The money it earns, or more accurately the money it raises, is being poured into R&D and capacity. Baillie Gifford's question cuts through attractive growth and asks whether the business itself makes money, and whether unit economics improve or deteriorate as scale increases. Rocket Lab's answer is: the trend is good, but the destination has not been reached.

  Gross margin: a clear upward trajectory, with scale improving unit economics.

  • FY2024 gross margin of 26% → full-year FY2025 improvement, and a Q1 2026 record of 38.2% GAAP / 43% non-GAAP. Lifting GAAP gross margin from 26% to 38%+ in two years is the textbook curve of volume growth, fixed-cost absorption, and improving unit economics. It shows the scaling direction is right.
  • The drivers are a rising Space Systems mix plus vertical integration (building satellites/payloads/platforms in-house and giving less margin away to external suppliers). Q1 2026 Space Systems revenue was $136.7 million, about 68% of revenue, and this business has a better gross-margin structure than pure launch.

  Bottom-line profit: still loss-making, and that is a hard flaw that must be stated clearly.

  • FY2025 net loss was $198.2 million and Adjusted EBITDA was -$101.2 million. The report text estimated FY2025 Adj EBITDA at -$30M and net loss at $200-250 million; actual Adj EBITDA loss was $101.2 million, much deeper than estimated, while net loss of $198.2 million was slightly better than the lower end of the estimated range.
  • Q1 2026 net loss narrowed to $45 million and Adjusted EBITDA was -$11.8 million. Losses are narrowing quarter by quarter, and the direction is right, but breakeven is still some distance away.

  Incremental returns: it is too early to conclude, because the largest capital investment, Neutron, has not generated revenue yet. Long-term unit economics will be determined by whether Neutron's reusable economics work. If first-stage recovery succeeds, per-launch cost structure should be materially better than expendable rockets. If it fails, a huge amount of R&D/CapEx is wasted. This remains an unrealized incremental-return bet.

  Where does the money it earns go? The answer is: there is no "earned" money to spend yet. It is spending raised cash and cash on hand, mainly on R&D and capacity.

  • No dividend; profits, which are in practice cash resources, are fully reinvested into R&D. Neutron development R&D and CapEx peaked in Q1 2026, and the $275 million Geost acquisition expanded payload capability.
  • Ammunition: cash and equivalents were $1.21 billion at the end of Q1 2026, with available liquidity above $2.0 billion. The report's "cash of $800 million" is outdated; the actual figure is $1.21 billion, and liquidity is more abundant after financing. It is not short of money in the near term, but continued cash burn means the dilution risk identified in the report is real. If Neutron is delayed again and losses extend, future equity issuance could still dilute shareholders.

  The honest Baillie Gifford view: this business's unit economics are improving but are not yet good. Gross margin is rising, scale effects are real, and losses are narrowing, so the direction is correct. But today it remains a loss-making business, positive free cash flow has not arrived, and the most important incremental return, Neutron's reusable economics, is still an uncashed check. Baillie Gifford can accept temporary losses for great growth, but this dimension should be marked as a watch item requiring Neutron delivery and continued proof of the profitability path. It has a trend toward improvement, but it has not yet earned the stamp of a good business.

  Jun 10, 2026
• QFor it to rise fivefold in ten years, what conditions must hold at the same time? Are those conditions realistic? What expectations are embedded in today's share price?3/10

  A

  A fivefold rise over ten years requires a long list of hard conditions to all hold at the same time. No single condition is absurd, but getting all of them right without failure is quite demanding, and today's share price has already pulled forward a large part of that optimistic scenario. This is the dimension where the Baillie Gifford framework should pour the most cold water on Rocket Lab, not because the company is poor, but because the price has already prepaid too much of the good.

  Start with today's base: the market cap is already giant. On 2026-06-09, the share price was about $119-120 (the previous day, 06-08, closed at $113.64), and market cap was about $67.6 billion. For a company with only $602 million of FY2025 revenue and a net loss of $198.2 million, that implies a price-to-sales ratio (PSR) of about 110x, the highest among all listed commercial space companies in the report's peer comparison and far above traditional defense giants LMT/NOC at 1.5-1.8x and L3Harris at 2.5x. A fivefold rise in ten years means market cap would need to move from about $67.6 billion to about $338.0 billion, close to 3x today's Lockheed Martin (about $110.0 billion).

  To deliver that target, the following conditions must hold at the same time:

  1. Neutron must achieve a timely successful maiden flight and then truly scale: 2026 Q4 maiden flight, with first-stage recovery plus reusable economics working, moving Rocket Lab into the SpaceX-dominated medium and large launch market and winning meaningful share. This is the largest and most binary prerequisite.
  2. Revenue must sustain high compound growth for ten years: from $600 million to tens of billions of dollars. To support a $338.0 billion market cap, even if PSR compresses to a reasonable 8-10x range by then, revenue would need to reach $34.0-42.0 billion, about 60x today's level. That requires SDA/defense, Neutron commercial launch, and Geost payloads to keep firing for many years.
  3. The company must turn from loss-making to meaningfully profitable: ten years from now, valuation cannot still be carried by a 110x PSR; it must switch to a profit anchor. It is still loss-making today (FY2025 -$198.2 million, Q1 2026 -$45 million) and needs to produce healthy net margins within several years.
  4. Large government programs such as Golden Dome / SDA must continue to ramp and not be cut by budgets or political cycles.
  5. SpaceX must not drive launch costs, through Starship, to a point where Neutron cannot compete, and it must not further move down into the small-satellite market.
  6. No major launch accident that destroys trust can occur within ten years, and ongoing financing must not excessively dilute shareholders.

  Are these conditions realistic? Viewed individually, each has a reasonable probability. But Baillie Gifford's real question is joint probability: six difficult events all need to avoid failure, and multiplying them makes the probability thin. Items 1 and 3 are especially critical and still undelivered: Neutron has already been delayed three times, triggered by a first-stage fuel-tank test failure, and the company remains unprofitable.

  What expectations are embedded in today's price? A large part of the optimistic case has already been priced in. The clearest evidence is the gap versus sell-side targets and fair-value estimates: the consensus target price from 18 analysts is about $102-107, already below the current price of about $119; multiple models estimate intrinsic value from about $73 (implying roughly 49% overvaluation) to about $104. In other words, the current price not only leaves no margin of safety for a fivefold return in ten years; it is already above most institutional estimates of fair value. The market is already embedding a fairly positive combination of Neutron maiden-flight success, FY2026 revenue heading toward $1.0 billion, smooth Geost integration, and continued SDA orders. The report's reasonable buy ceiling is $75, and the current price is about 50% above that.

  The honest Baillie Gifford view: the numerator for a ten-year fivefold return, meaning company potential, exists. The long runway, thick backlog, and early moat are real. But the denominator, today's price, has prepaid too much of that upside imagination, leaving insufficient or even negative margin of safety. Baillie Gifford is willing to pay a premium for great companies, but not to enter when the optimistic scenario is already priced and the key prerequisites, Neutron and profitability, have not yet been delivered. For it to rise fivefold over ten years, a chain of hard conditions must all hold, and the stock must first digest the current overpayment. That is the core reason the report rates it Watch rather than Buy.

  Jun 10, 2026
• QWhy has the market not realized all this yet? Is it because investors do not understand it, look down on it, or cannot see far enough? What will become the narrative inflection point?3/10

  A

  The market actually understands it too well and sees too far. This is one of the rare names where the narrative inflection point is already widely recognized, even over-priced. The problem is not that nobody has realized the story; it is that everyone has. The essence of Baillie Gifford's question is to find perception gaps: does the market fail to understand it, dismiss it, or fail to see far enough? The larger the perception gap, the greater the future excess-return opportunity. For Rocket Lab, the honest answer is: the perception gap is already very small, and may even run in reverse, meaning overvaluation rather than undervaluation.

  "Investors do not understand it"? Not true. It is heavily studied. Rocket Lab is one of Wall Street's most covered and retail investors' hottest "commercial space number two / SpaceX alternative" stocks. 18 analysts cover it continuously, with a consensus Buy, and everyone can recite the bull narrative of "Golden Dome + SDA + Neutron option." Its moat, backlog, and Neutron timeline have been repeatedly modeled by the sell side. This is not a neglected cognitive blind spot hiding in a corner.

  "Investors look down on it"? The opposite is true. The market gives it the industry's highest respect premium. At a current price of about $119-120, market cap of about $67.6 billion, and PSR of about 110x, it sits at the top of listed commercial space valuations in the report's peer comparison, far above traditional defense giants. Over the past year, market cap rose from about $37.7 billion to about $67.6 billion, up +79% (the report's framing is +1100% over the past 24 months). The market is not looking down on it; it is chasing it as the future SpaceX. Sentiment is a premium, not a discount.

  "Investors cannot see far enough"? This is the only possible direction for a perception gap, but the direction is that the market sees too far and pulls future upside forward, not that it cannot see far enough. The market has already discounted Neutron maiden-flight success, commercial ramp, and full-stack defense delivery into today's share price. The evidence is that the current price of about $119 is already above the 18-analyst consensus target of about $102-107 and also above multiple models' intrinsic-value estimates of about $73-104. When the price has already run ahead of consensus targets and fair value, it means the market is not "failing to see far enough". It is seeing too far and treating good things that have not happened as if they already have. In that situation, the Baillie Gifford perception-gap payoff is negative: you are not buying an underappreciated long-term story, but an overpriced optimistic one.

  So what becomes the narrative inflection point? It can inflect upward or downward, and most paths still run through the single ignition point of Neutron:

  • Upward inflection, delivery type: successful Neutron maiden flight in 2026 Q4 plus first-stage recovery validation turns the SpaceX-alternative story from narrative into fact, shifts the valuation anchor from PSR to real medium-lift launch share, and could support another leg; or a new several-hundred-million-dollar SDA Tranche 3 / Golden Dome award could validate the full-stack defense narrative.
  • Downward inflection, falsification type, which the report judges as the higher-probability risk: another Neutron delay or maiden-flight failure resets market expectations for the alternative-player story, pulls PSR from about 110x toward mean reversion at 25-35x, and could halve the stock; or one quarter missing revenue guidance (Q2 2026 guidance is $225-240 million) could trigger a one-day selloff under a zero-tolerance high-valuation setup.

  The honest Baillie Gifford view: this dimension is where Rocket Lab is most awkward in the Baillie Gifford framework. Baillie Gifford makes money from situations where the market has not yet realized something. Rocket Lab is the reverse case, where the market has long since realized the story and has already over-priced it. The perception gap is small, even negative. Its narrative inflection point is binary, tied to one Neutron maiden flight, and today's price makes the damage from a downward inflection much larger than the upside elasticity from an upward one. Downside has the deep pit of PSR mean reversion, while upside good news has already been prepaid. This is the textbook case of "excellent company does not equal excellent entry point," and the fundamental logic behind the report's recommendation to Watch and only enter after a pullback to ≤$75.

  Jun 10, 2026